NanoGroup enters into investor agreements to secure financing for NanOX development process
On August 25 and 26, 2025, NanoGroup signed investor agreements for a total of 17 PLN million.
Who has invested in NanoGroup?
- The Chairman of the Supervisory Board, the President of the Management Board, some executives and existing shareholders of NanoGroup, as well as new individual investors. One of the new investors is a mutual fund founder with extensive international experience.
What will the investment be used for?
Securing funding for NanOX 4 Kidney project
The purpose of the investment is to provide the entire contribution to the funding agreement concluded on August 4, 2025, according to which the amount of funding obtained is PLN 22.8 million. Upon completion of the investment process NanoGroup will have secured financing for the entire NanOX system development process, up to the start of the certification and release process. The NanOX system is currently NanoGroup’s strategic project, and its implementation is proceeding on schedule and without disruption. Securing financing for the entire development process of a key project significantly will lower The risk of investing in NanoGroup.
New projects
Funds will also be used to develop new projects, including those based on the aptamer platform acquired from Pure Biologics and in the area of blood substitutes.
Why is the world of transplantation waiting for the NanOX system?
- Normothermic perfusion (NMP) is the future of transplantation because:
- can repair/rehabilitate organs
- allows for a significant increase in storage time
- allows to evaluate the organ “live” before transplantation.
- In NMP, oxygenation is key, and perfusates based on donor blood or erythrocytes have limitations (pathogen risk, short stability, need for blood grouping, very high cost).
- The NanOX system will help replace blood in perfusion and simplify logistics.
According to our estimates, the NanOX system will make it possible to increase the amount of organs harvested by up to two times.
At the same time, the company is in talks with another potential investor interested in participating in the venture.
We secure the funds and mitigate the risks.
#StayNanoTuned!